The EPS projection of Ovascience Inc. (NASDAQ:OVAS) for period quarter completed 2016-12-31 is $-0.61.
The EPS estimates pronounced a week and 30 days ago were $-0.61 and $-0.61 correspondingly. The EPS forecasts specified 60 and 90 days before were $-0.61 and $-0.61 respectively. From a week ago, the aberration in EPS forecast is -0.01 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $-0.61 based on 2 EPS estimations. The EPS stated on 2016-08-04 was $-0.62. The EPS surprise was $0.2, or 24.39 percent. The standard deviation as per known EPS estimates was $0.01.
The positive EPS revisions were 0 a week earlier and negative revisions were 0. In last 30 and 60 days, the positive EPS revisions were 0 and 1 correspondingly, while for 90 and 120 days, revisions count was 2 and 2.
The negative revisions of per-share earnings in the last 30 and 60-days were 0 and 0 in that order. however, for 90 and 120 days’ period, the count was 0 and 0 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 1 and 0 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Ovascience Inc. (NASDAQ:OVAS) is $0.308 and the median was $0.308. The estimate is stated by 2 analysts for the fiscal 2016.
The highest annual projection is $0.316 and lowest sales target is $0.3. This marks a standard deviation of $0.011.
Almost 2 have given revised positive sales forecast in the past week and 2 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 0 percent.
Nearly 2 have revised sales projections in positive side over the past month and 2 have downgraded forecasts. This shows a mean estimate deviation of 0 percent.
Just about 2 have revised sales forecast on plus side over the quarter and 2 have downgraded forecasts. This shows mean estimate deviation of -77.567 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...